Le Lézard
Classified in: Health
Subject: WOM

Not All Orgasm Doctors are the Same


FAIRHOPE, Ala., Jan. 16, 2018 /PRNewswire/ -- Orgasm Shot® (O-Shot®), the Priapus Shot® (P-Shot®), the Vampire Facelift® & Vampire Facial®?gained attention this month in Men's Health, the Sun, and others. All of these procedures are the inventions of Dr. Charles Runels, MD?called the "Orgasm Doctor" by Cosmopolitan & by the Guardian.

Dr. Charles Runels, MD

Both the Orgasm Shot® & the Priapus Shot® represent very specific methods for improving sexual function in women and in men (respectively).

The Orgasm Shot® (O-Shot®) evolved out of Dr. Runels' work with the Vampire Facelift® & Vampire Facial® procedures made famous by Kim Kardashian after she featured the procedures on her reality TV show?all of these procedures use blood-derived growth factors to rejuvenate tissue. Since The Guardian published a feature article about Dr. Runels and since the publication of his research papers, the O-Shot® procedure went viral and is now offered by 1,342 providers in universities and offices in 49 countries.

Men's Health reported in its February 2018 edition (with Mark Wahlberg on the cover) the adventures and very impressive results of a man who decided to improve his sex using the Priapus Shot® as part of a New Year's resolution.

This month, the Sun also reported about a woman in London who was delighted about becoming multi-orgasmic after being treated with the O-Shot® by Dr. Shirin Lakhini (who teaches for Dr. Runels). In preparation for her wedding, the woman saw Dr. Lakhini in consultation and received the Orgasm Shot®.

The Orgasm Shot® & Priapus Shot® procedures are taught in Europe, North America, South America, Asia, Africa, Australia, and New Zealand by over 40 teachers (all who trained with Dr. Runels). Teacher's specialty trainings include certifications in urology, gynecology, urogynecolgy, plastic surgery, and others.

The providers of the procedures are licensed worldwide by the Cellular Medicine Association (CMA) based in the us but with members totally approximately 2,000 providers in over 50 countries. The Cellular Medicine Association coordinates and supports the research and clinical practice of physicians using cellular medicine for the improvement of health, beauty and sexual relations. The group includes over 2,000 doctors in 47 countries and was founded by Dr. Runels.

The terms O-Shot®, Orgasm Shot®, Priapus Shot®, P-Shot®, Vampire Facelift®, Vampire Facial®, are proper names, to be capitalized with the "®" symbol following. These names represent very specific methods designed by Dr. Runels and modified over time with the input of physicians in the CMA. The names are protected by trademark law and should only be used by providers certified by the Cellular Medicine Association.

Contact:
Charles Runels, MD
Medical Director
Cellular Medicine Association
888-920-5311 phone
251-650-1251 fax
[email protected]

http://CellularMedicineAssociation.org

SOURCE Cellular Medicine Association


These press releases may also interest you

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: